Article
Genomic analysis reveals low tumor mutation burden which may be associated with GNAQ/11 alteration in a series of primary leptomeningeal melanomas.
Pigment cell & melanoma research - 1 May 2020
Fortin Ensign Shannon, Bollin Kathryn, Millis Sherri Z, Hinds Brian R, Kosty Michael, Uchiyama Christopher
Abstract excerpt
Primary central nervous system melanoma is rare and characterized by a variable prognosis, and no current treatment guidelines exist. We describe the clinical course of a 70-year-old female patient diagnosed with primary leptomeningeal melanoma (LMN) whose case represents the diagnostic and management challenges of this tumor. Targeted genomic sequencing of 315 genes from this tumor revealed GNAQ Q209L mutation...
Topics
- Aged
- Cohort Studies
- Female
- GTP-Binding Protein alpha Subunits
- GTP-Binding Protein alpha Subunits, Gq-G11
- Genetic Association Studies
- Genetic Predisposition to Disease
- Genomics
- Humans
- Meningeal Neoplasms
